Krka Tovarna Zdravil D.D. 

$0.000000
100
+$0.00+0%Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 2026
$8.18
Jul 2025
$8.18
Jul 2024
$8.18
Jul 2023
$7.41
Jul 2022
$5.76
10Y Growth
11.09%
5Y Growth
17.92%
3Y Growth
11.56%
1Y Growth
10.4%

Financials

17.39%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
1.96BRevenue
341.29MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Krka in various therapeutic areas.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Krka's offerings in the global market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap46.1B
Teva Pharmaceutical Industries is a leading generic and specialty pharmaceutical company, competing with Krka in the generics market.
Merck
MRK
Mkt Cap356.01B
Merck & Co. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Krka in several therapeutic areas.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline is a global healthcare company that produces pharmaceuticals and vaccines, directly competing with Krka in various markets.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie is a biopharmaceutical company that develops and markets therapies, competing with Krka in the areas of chronic diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that operates in pharmaceuticals and diagnostics, competing with Krka in the development and marketing of drugs.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is a global biopharmaceutical company, competing with Krka in the discovery, development, and delivery of medicines.
Sanofi
SNY
Mkt Cap95.65B
Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions, competing with Krka in various therapeutic areas.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Krka in developing and commercializing prescription medicines.

About

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabolism, and other therapeutic areas, as well as analgesics, vitamins, minerals, and vasoprotectives. In addition, the company offers animal health products, including antiparasitics, antimicrobials, and other products. Further, it provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.
Show More
CEO
Joze Colaric
Country
Other
ISIN
SI0031102120

Listings

0 Comments

Share your thoughts

FAQs

What is Krka Tovarna Zdravil D.D. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Krka Tovarna Zdravil D.D. stocks are traded under the ticker KRKAF.
What is Krka Tovarna Zdravil D.D. revenue for the last year?▼
Krka Tovarna Zdravil D.D. revenue for the last year amounts to 1.96B USD.
What is Krka Tovarna Zdravil D.D. net income for the last year?▼
KRKAF net income for the last year is 341.29M USD.
Does Krka Tovarna Zdravil D.D. pay dividends?▼
Yes, KRKAF dividends are paid annual. The last dividend per share was 8.18 . As of today, Dividend Yield (FWD)% is 0%.
In which sector is Krka Tovarna Zdravil D.D. located?▼
Krka Tovarna Zdravil D.D. operates in the Technology sector.
When did Krka Tovarna Zdravil D.D. complete a stock split?▼
Krka Tovarna Zdravil D.D. has not had any recent stock splits.
Where is Krka Tovarna Zdravil D.D. headquartered?▼
Krka Tovarna Zdravil D.D. is headquartered in Smarjeska Cesta 6, Other.